default author photo

Andrew M. Baschnagel

University of Wisconsin-Madison - Department of Human Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

155

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Inhibition of Androgen Receptor Signaling Reduces Inflammation in the Lung with SARS-CoV-2 Infection Through Dampening IL6 Signaling

Number of pages: 33 Posted: 19 Jul 2022
University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison - Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison - Department of Human Oncology, West High School, University of Wisconsin-Madison - Carbone Cancer Center, University of Wisconsin-Madison - Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison - Department of Human Oncology and University of Wisconsin-Madison - Department of Human Oncology
Downloads 96 (709,832)

Abstract:

Loading...

COVID-19, Androgen receptor, SARS-CoV-2, IL-6, enzalutamide

2.

Coordinated Immune-Extracellular Matrix Transcriptional Changes Drive Brain Metastatic Progression in Lung Adenocarcinoma

Number of pages: 55 Posted: 07 Apr 2025
University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison - Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison - Carbone Cancer Center, University of Wisconsin-Madison - Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison - Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison - Department of Human Oncology and Independent
Downloads 31 (1,304,549)

Abstract:

Loading...

Lung-to-brain metastasis, NSCLC brain colonization, ECM-immune crosstalk, transcriptomic trajectory, LUAD molecular subtypes, COL1A1-integrin axis, stage III LUAD prognosis, brain metastasis biomarkers, HOXC10-PD-L2 pathway, immunosuppressive microenvironment, matched tissue

3.

Dares: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer

Number of pages: 19 Posted: 26 Jun 2024
University of Chicago, affiliation not provided to SSRN, University of Chicago, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Chicago, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Kansas - University of Kansas Medical Center, University of Kansas - Department of Internal Medicine, University of Wisconsin-Madison - Department of Human Oncology, University of Wisconsin-Madison, University of Chicago and University of Chicago
Downloads 28 (1,345,526)

Abstract:

Loading...

extensive-stage small cell lung cancer, immunotherapy, chemoimmunotherapy, ablative radiation, stereotactic body radiation therapy